| 2091 |
NAPPY HIPPO |
ZINC OXIDE 7.50G/100G |
CREAM |
TUBE AND JAR |
EMOLLIENT AND ASTRINGENT SKIN APPLICATION. PARTICULARLY FOR NAPPY RASH IN INFANTS |
NULL |
PALAMY PHARMA CO., LTD |
SRIPRASIT PHARMA CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
11 I 2451/04 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 2092 |
NEVOL 2.5 TABLETS |
NEBIVOLOL HYDROCHLORIDE EQ.TO NEBIVOLOL 2.5 MG |
TABLET |
ALU-PVC BLISTER |
TREATMENT OF MILD TO MODERATE ESSENTIAL HYPERTENSION |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICAL LTD |
INDIA |
CERTIFICATE RELEASED |
08 I 4539/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2093 |
NEVOL 5 TABLETS |
NEBIVOLOL HYDROCHLORIDE EQ.TO NEBIVOLOL 5 MG |
TABLET |
ALU-PVC BLISTER |
TREATMENT OF MILD TO MODERATE ESSENTIAL HYPERTENSION |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICAL LTD |
INDIA |
CERTIFICATE RELEASED |
08 I 4540/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 2094 |
OMENIX 40 |
OMEPRAZOLE SODIUM BP 44.6323 MG EQ. TO OMEPRAZOLE 40 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
HEARTBURN, ANY SYMPTOMS OF GERD, EROSIVE ESOPHAGITIS, GASTRIC ULCER, DUODENAL ULCER AND REDUCTION OF RISK OF UPPER GI BLEEDING IN CRITICALLY ILL PATIENTS, PRIMARILY FOR THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME |
NULL |
PALAMY PHARMA CO., LTD |
INCEPTA PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
05 I 3321/09 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2095 |
ONCET |
CETIRIZINE DIHYDROCHLORIDE BP 10 MG |
TABLET |
ALU-ALU BLISTER |
FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS DUE TO ALLERGENS SUCH AS RAGWEED, GRASS AND TREE POLLENS, PARENNIAL ALLERGIC RHINITIS, CHRONIC URTICARIA, PRURITUS, ALLERGIC CONJUNCTIVIS. |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICALS LTD. |
INDIA |
CERTIFICATE RELEASED |
03 I 4028/15 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2096 |
ORICH PLUS |
VITAMIN A 5000 IU, VITAMIN E 15MG, VITAMIN C 75MG, ZINC SULPHATE MONOHYDRATE 7.5MG, COPPER SULPHATE ANHYDROUS 1MG, MANGANESE SULPHATE 1.5MG, BETA CAROTENE 10MG, SELENIUM 150MCG |
CAPSULE |
ALU-PVC BLISTER |
METABOLIC DISEASE LIKE DIABETES MELLITUS, CARDIOVASCULAR DISEASE, CEREBROVASCULAR DISEASE LIKE STROKE, NEUROLOGICAL DISEASES LIKE ALZHEIMER'S DISEASE. DEGENERATIVE DISEASE OF THE EYE SUCH AS CATARACT AND MACULAR DEGENERATIVE IN THE ELDERLY. |
NULL |
PALAMY PHARMA CO., LTD |
ZEE LABOBORATORIES |
INDIA |
CERTIFICATE RELEASED |
02 I 2725/06 |
9-JUL-2024 |
8-JUL-2027 |
View |
| 2097 |
OSSIFIX |
CALCIUM CARBONATE USP 1.250 MG EQ.TO ELEMENTAL CALCIUM 500 MG, MAGNESIUM OXIDE USP 50 MG, VITAMINE D3 BP 250 IU, ZINC SULPHATE MONOHYDRATE USP 35 MG, LYSINE HYDROCHLORIDE USP 100MG |
FILM COATED TABLET |
ALU-PVC BLISTERPACK |
PREDIALYSIS PATIENTS: IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENALFAILURE NOT YET ON DIALYSIS. DIALYSIS PATIENTS: FOR MANAGEMENT OF HYPOCALCEMIA AND THE RESULTANT METABOLIC BONE DISEASE IN PATIENTS UNDERGOING CHRONIC RENAL DIALYSIS |
NULL |
PALAMY PHARMA CO., LTD |
ZEE LABOBORATORIES |
INDIA |
CERTIFICATE RELEASED |
02 I 2732/06 |
07-FEB-2024 |
06-FEB-2027 |
View |
| 2098 |
OZIP-10 |
OLANZAPINE 10 MG |
FILM COATED TABLET |
ALU-BLISTER |
FOR THE MANAGEMENT OF THE MANISFESTATIONS OF PSYCHOTIC DISORDERS |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICALS LTD |
INDIA |
CERTIFICATE RELEASED |
02 I 3429/10 |
16-JAN-2025 |
15-JAN-2030 |
View |
| 2099 |
PANTAZ |
PANTOPRAZOLE SODIUM SESQUIHYDRATE USP EQ.TO PANTOPRAZOLE 40MG |
TABLET |
ALU-ALU BLISTER |
GASTRIC ULCER, DUODENAL ULCER, MODERATE AND SEVERE REFLUX ESOPHAGITIS, IN COMBINATION WITH ANTIBIOTICS FOR THE ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH PEPTIC ULCERS WITH THE OBJECTIVE OF REDUCING THE RECURRENT OF DUODENAL AND GASTRIC ULCERS CAUSED BY THIS MICROORGANISMS. |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICALS LTD |
INDIA |
CERTIFICATE RELEASED |
07 I 3388/09 |
19-MAY-2023 |
18-MAY-2026 |
View |
| 2100 |
PLATFREE TABLET |
CLOPIDOGREL BISULFATE USP EQUIVALENT TO CLOPIDOGREL 75 MG |
FILM-COATED TABLETS |
ALUMINIUM FOIL |
CLOPIDOGREL IS INDICATED FOR THE REDUCTION OF ATHEROSCLOTIC EVENTS ( MYOCARDIAL INFARCTION, STROKE AND VASCULAR DEATH) IN PATIENTS WITH ATHEROSCLEROSIS DOCUMENTED BY RECENT STROKE, RECENT MYCOCARDIAL INFARCTION, OR ESTABLLISHED PERIPHERAL ARTERIAL DISSEAS |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICAL LTD |
INDIA |
CERTIFICATE RELEASED |
11 I 3983/13 |
16-JAN-2025 |
15-JAN-2030 |
View |
